Jiangsu Hengrui Pharmaceuticals Co.,Ltd (600276.SS)
Develops cancer and disease medicines for patients in China and globally.
53.89+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-12.1%
The outlook
Jiangsu Hengrui trades near the lower end of its 52-week range and sits between its moving averages in mixed territory. Analyst sentiment leans bearish overall, and the stock carries a trailing P/E of 44.2, suggesting elevated valuation relative to current earnings.
What’s behind the score
Price trendMixed vs its moving averages
52-week range30% of the way from its 52-week low to high
Market cap
$357.68B
52-wk high
74.04
52-wk low
45.26
50-day avg
51.31
200-day avg
56.98
Trailing P/E
44.2